Denosumab for Osteoporosis Treatment in Rheumatic Diseases: What Do We Know 15 Years Post Approval? Cohen SB, Saag KG. J Rheumatol 2025 Aug 1:jrheum.2025-0726. doi: 10.3899/jrheum.2025-0726.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cohen SB, Saag KG. Denosumab for Osteoporosis Treatment in Rheumatic Diseases: What Do We Know 15 Years Post Approval? J Rheumatol 2025 Aug 1:jrheum.2025-0726. doi: 10.3899/jrheum.2025-0726.
PMID: 40750319